FundedStartupsDaily / HealthTech / Prevision Medicine

Prevision Medicine raises $5.4M

Prevision Medicine announced a Seed round of $5.4M on 24 September 2026. The company operates in HealthTech and is based in Switzerland. It was founded by Philip Zimmermann, CEO & Co-Founder. Announced yesterday.

Raised
$5.4M
Stage
Seed
Industry
HealthTech
Country
Switzerland

Founder

Philip Zimmermann
CEO & Co-Founder, Prevision Medicine

Outreach angles

  • -Philip Zimmermann, who holds a Doctor of Engineering degree, founded Prevision Medicine after prior roles connected to Nebion and the Immunai Group.
  • -Zimmermann's background includes work tied to ETH Zurich precision medicine research before commercializing the platform.
  • -The seed round will fund regulatory clearances and operational expansion of the company's functional oncology testing platform across Europe.

Signals

SeedHealthcareDeep TechRegulated IndustryNew Market

Round details

Company: Prevision Medicine
Domain: previsionmedicine.com
Amount: $5.4M
Stage: Seed
Industry: HealthTech
Country: Switzerland
Announced: 24 September 2026
Source: announcement

Other HealthTech raises

Recently funded in Switzerland